Celerion (United States)

American contract research organisation headquartered at Lincoln in Nebraska, created in 2010 when the early development business of Covance was sold, with clinical research units at Lincoln, Tempe in Arizona and Belfast in Northern Ireland and bioanalytical laboratories in the United States and Switzerland. Runs first in human and other phase one studies, bioequivalence and bioavailability trials, patient and special population studies and cardiac safety work, and provides bioanalysis of small molecules and biologics, pharmacokinetic and pharmacodynamic modelling, biostatistics and regulatory consulting.